Aptamer mediated delivery of small interfering RNAs

Progress in Biochemistry and Biophysics

Volumn 39, Issue 5, 2012, Pages 410-415

  Tan, Yan ^a   Zhang, Xing Mei ^a  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

Author keywords

Aptamer; Delivery; SELEX; SiRNA

Indexed keywords

EID: 84865014074     PISSN: 10003282     EISSN: None     Source Type: Journal    
DOI: 10.3724/SP.J.1206.2011.00619     Document Type: Review

References (38)

1. Zhan L S, Shao N S, Peng J C, et al. Prog Biochem Biophys, 2003, 30(1): 151-155
2. Shao N S, Li S H, Huang Y P, et al. Prog Biochem Biophys, 2006, 33(4): 329-335
3. Zhou J, Rossi J J. Bivalent aptamers deliver the punch. Chem Biol, 2008, 15(7): 644-645 (Pubitemid 351957916)
4. Elbashir S M, Harborth J, Lendeckel W, et al. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature, 2001, 411(6836): 494-498 (Pubitemid 32494397)
5. Xie F Y, Woodle M C, Lu P Y. Harnessing in vivo siRNA delivery for drug discovery and therapeutic development. Drug Discov Today, 2006, 11(1-2): 67-73 (Pubitemid 43227854)
6. Sioud M. On the delivery of small interfering RNAs into mammalian cells. Expert Opin Drug Deliv, 2005, 2(4): 639-651 (Pubitemid 41038677)
7. Behlke M A. Progress towards in vivo use of siRNAs. Mol Ther, 2006, 13(4): 644-670
8. Fountaine T M, Wood M J, Wade-Martins R. Delivering RNA interference to the mammalian brain. Curr Gene her, 2005, 5(4): 399-410
9. Lewis D L, Wolff J A. Delivery of siRNA and siRNA expression constructs to adult mammals by hydrodynamic intravascular injection. Methods Enzymol, 2005, 392: 336-350 (Pubitemid 40092524)
10. Anderson J, Banerjea A, Planelles V, et al. Potent suppression of HIV type 1 infection by a short hairpin anti-CXCR4 siRNA. AIDS Res Hum Retroviruses, 2003, 19(8): 699-706
11. Devroe E, Silver P A. Therapeutic potential of retroviral RNAi vectors. Expert Opin Biol Ther, 2004, 4(3): 319-327 (Pubitemid 38352128)
12. Wu Y, Navarro F, LaI A, et al. Durable protection from Herpes Simplex Virus-2 transmission following intravaginal application of siRNAs targeting both a viral and host gene. Cell Host Microbe, 2009, 5(1): 84-94
13. Song E, Zhu P, Lee S K, et al. Antibody mediated in vivo delivery of small interfering RNAs via cell-surface receptors. Nat Biotechnol, 2005,23(6): 709-717 (Pubitemid 41716361)
14. Liu H, Rajasekaran A K, Moy P, et al. Constitutive and antibody-induced internalization of prostate-specific membrane antigen. Cancer Res, 1998, 58(18): 4055-4060 (Pubitemid 28440554)
15. Lupoid S E, Hicke B J, Lin Y, et al. Identification and characterization of nuclease-stabilized RNA molecules that bind human prostate cancer cells via the prostate-specific membrane antigen. Cancer Res, 2002, 62(14): 4029-4033 (Pubitemid 34791070)
16. Farokhzad O C, Jon S, Khademhosseini A, et al. Nanoparticleaptamer bioconjugates: A new approach for targeting prostate cancer cells. Cancer Res, 2004,64(21): 7668-7672 (Pubitemid 39446893)
17. McNamara J O 2nd, Andrechek E R, Wang Y, et al. Cell type specific delivery of siRNAs with aptamer-siRNA chimeras. Nat Biotechnol, 2006, 24(8): 1005-1015
18. Chu T C, Twu K Y, Ellington A D, et al. Aptamer mediated siRNA delivery. Nucleic Acids Res, 2006, 34(10): e73
19. Hicke B J, Stephens A W, Could T, et al. Tumor targeting by an aptamer. J Nucl Med, 2006, 47(4): 668-678 (Pubitemid 46768469)
20. Perkins A C, Missailidis S. Radiola belled aptamers for tumour imaging and therapy. Q J Nucl Med Mol Imaging, 2007, 51 (4): 292-296 (Pubitemid 350267699)
21. Chu T C, Marks J W 3rd, Lavery L A, et al. Aptamer: toxin conjugates that specifically target prostate tumor cells. Cancer Res, 2006, 66(12): 5989-5992
22. Bagalkot V, Farokhzad O C, Langer R, et al. An aptamerdoxorubicin physical conjugate as a novel targeted drug-delivery platform. Angew Chem Int Ed Engl, 2006, 45(48): 8149-8152 (Pubitemid 44974149)
23. Dassie J P, Liu X Y, Thomas G S, et al. Systemic administration of optimized aptamer-siRNA chimeras promotes regression of PSMA-expressing tumors. Nat Biotechnol, 2009, 27(9): 839-849
24. Zhou J, Li H, Li S, et al. Novel dual inhibitory function aptamer-siRNA delivery system for HIV-I therapy. Mol Ther, 2008, 16(8): 1481-1489
25. Zhou J, Swiderski P, Li H, et al. Selection, characterization and application of new RNA HIV gp 120 aptamers for facile delivery of Dicer substrate siRNAs into HIV infected cells. Nucleic Acids Res, 2009, 37(9): 3094-3109
26. Zhou J, Li H, Zhang J, et al. Development of cell-type specific anti-HIV gp120 aptamers for siRNA delivery. J Vis Exp, 2011, (52). pii: 2954
27. Wheeler L A, Trifonova R, Vrbanac V, et al. Inhibition of HIV transmission in human cervicovaginal expiants and humanized mice using CD4 aptamer-siRNA chimeras. J Clin Invest, 2011, 121(6): 2401-2412
28. Shaw B R, Moussa L, Sharaf M, et al. Boranophosphate siRNAaptamer chimeras for tumor-specific downregulation of cancer receptors and modulators. Nucleic Acids Symp Ser (Oxf), 2008, (52): 655-656
29. Pestourie C, Tavitian B, Duconge F. Aptamers against extracellular targets for in vivo applications. Biochimie, 2005, 87(9-10): 921930
30. Nimjee S M, Rusconi C P, Sullenger B A. Aptamers: an emerging class of therapeutics. Annu Rev Med, 2005, 56: 555-583 (Pubitemid 40299797)
31. Chen C H, Dellamaggiore K R, Ouellette C P, et al. Aptamer-based endocytosis of a lysosomal enzyme. Proc Natl Acad Sci USA, 2008, 105(41): 15908-15913
32. Xiao Z, Shangguan D, Cao Z, et al. Cell-specific internalization study of an aptamer from whole cell selection. Chemistry, 2008, 14(6): 1769-1775
33. Huang Y F, Shangguan D, Liu H, et al. Molecular assembly of an aptamer-drug conjugate for targeted drug delivery to tumor cells. Chembiochem, 2009,10(5): 862-868
34. Liu H, Rajasekaran A K, Moy P, et al. Constitutive and antibodyinduced internalization of prostate-specific membrane antigen. Cancer Res, 1998, 58(18): 4055-4060 (Pubitemid 28440554)
35. Lupoid S E, Hicke B J, Lin Y, et al. Identification and characterization of nuclease-stabilized RNA molecules that bind human prostate cancer cells via the prostate-specific membrane antigen. Cancer Res, 2002,62(14): 4029-4033 (Pubitemid 34791070)
36. Zhang K, Sefah K, Tang L, et al. A novel aptamer developed for breast cancer cell internalization. Chem Med Chem, 2012, 7(1): 79-84
37. Wullner U, Neef I, Eller A, et al. Cell-specific induction of apoptosis by rationally designed bivalent aptamer-siRNA transcripts silencing eukaryotic elongation factor 2. Curr Cancer Drug Targets, 2008, 8(7): 554-565
38. Zhou J, Rossi J J. The therapeutic potential of cell-internalizing aptamers. Curr Top Med Chem, 2009, 9(12): 1144-1157